Skip to Main Content

Author Details

Laura H Mariani
University of Michigan ann arbor
2011
75
25
PMIDPaper TitleJournal TitlePublished Year
36442540Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.Kidney Int2023
37901701Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome.Glomerular Dis2023
37901700CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.Glomerular Dis2023
37580326An integrated organoid omics map extends modeling potential of kidney disease.Nat Commun2023
37543648Clustering-based spatial analysis (CluSA) framework through graph neural network for chronic kidney disease prediction using histopathology images.Sci Rep2023
37733352The Significance of Hematuria in Podocytopathies.Clin J Am Soc Nephrol2023
37060902Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight.Cell Metab2023
37016482Clinical Relevance of Computationally Derived Attributes of Peritubular Capillaries from Kidney Biopsies.Kidney3602023
37284673Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach.Kidney Int Rep2023
37069998Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease.Kidney Int Rep2023
37069979Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy.Kidney Int Rep2023
37131280Clinical Course of Adult FSGS and Minimal Change Disease in North American and Japanese Cohorts.Kidney3602023
36853804KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression.JCI Insight2023
34864148Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.Am J Kidney Dis2022
35477557Molecular Characterization of Membranous Nephropathy.J Am Soc Nephrol2022
35581011Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis.J Am Soc Nephrol2022
37113495Ridge Regression for Functional Form Identification of Continuous Predictors of Clinical Outcomes in Glomerular Disease.Glomerular Dis2022
36411058Effects of Bardoxolone Methyl in Alport Syndrome.Clin J Am Soc Nephrol2022
36339665Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study.Kidney Med2022
36175144Authors' Reply: <i>In Silico</i>-Based Approach to the Discovery of New Antigens in Membranous Nephropathy.J Am Soc Nephrol2022
36055599Molecular programs associated with glomerular hyperfiltration in early diabetic kidney disease.Kidney Int2022
35318420Unsupervised machine learning for identifying important visual features through bag-of-words using histopathology data from chronic kidney disease.Sci Rep2022
34901577Validation of Diagnosis Codes to Identify Infection-Related Acute Care Events in Patients With Glomerular Disease.Kidney Int Rep2021
35419531Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet Data.Kidney3602021
36747902Current Understanding of Clinical Manifestations of COVID-19 in Glomerular Disease.Glomerular Dis2021
33685977Automated Quantification of Chronic Changes in the Kidney Biopsy: Another Step in the Right Direction.J Am Soc Nephrol2021
33851061Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network.Contemp Clin Trials Commun2021
33789284Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.Am J Nephrol2021
33637194Rationale and design of the Kidney Precision Medicine Project.Kidney Int2021
31606232Health Outcomes and Health Care Utilization Among Obstetric Deliveries With Concurrent CKD in the United States.Am J Kidney Dis2020
32086276Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes.J Am Soc Nephrol2020
32107344Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker.JCI Insight2020
33082200Infection-Related Acute Care Events among Patients with Glomerular Disease.Clin J Am Soc Nephrol2020
33367284Understanding the Link between Neighborhoods and Kidney Disease.Kidney3602020
33038424SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.Kidney Int2020
32775980Estimated GFR Trajectories in Pediatric and Adult Nephrotic Syndrome: Results From the Nephrotic Syndrome Study Network (NEPTUNE).Kidney Med2020
32717100Incorporating longitudinal biomarkers for dynamic risk prediction in the era of big data: A pseudo-observation approach.Stat Med2020
32359808Machine learning, the kidney, and genotype-phenotype analysis.Kidney Int2020
32354727JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy.Clin J Am Soc Nephrol2020
32561683Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis.J Am Soc Nephrol2020
32231244The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis.Nat Commun2020
32511461SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease.medRxiv2020
32424281Integrated multi-omics approaches to improve classification of chronic kidney disease.Nat Rev Nephrol2020
30420158CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.Am J Kidney Dis2019
31732612Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.J Am Soc Nephrol2019
30249420Using All Longitudinal Data to Define Time to Specified Percentages of Estimated GFR Decline: A Simulation Study.Am J Kidney Dis2019
31416887Methods for Assessing Longitudinal Biomarkers of Time-to-Event Outcomes in CKD: A Simulation Study.Clin J Am Soc Nephrol2019
31396499Evolving Clinical Applications of Tissue Transcriptomics in Kidney Disease.Front Pediatr2019
30704883Correlation Between Baseline GFR and Subsequent Change in GFR in Norwegian Adults Without Diabetes and in Pima Indians.Am J Kidney Dis2019
30975656Pruritus and Patient Reported Outcomes in Non-Dialysis CKD.Clin J Am Soc Nephrol2019
  • 1 - 50 of 75

Recommended Authors

Sherry G Mansour
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 10
Caitlyn Vlasschaert
Queen's University
Career Start Year 2014
Number of shared co-authors 3
Anand Srivastava
Global Institute of Stem Cell Therapy and Research 4660 La Jolla Village Drive
Career Start Year 2012
Number of shared co-authors 14
Farrukh M Koraishy
Stony Brook University Hospital
Career Start Year 2011
Number of shared co-authors 2
Girish N Nadkarni
Icahn School of Medicine at Mount Sinai
Career Start Year 2010
Number of shared co-authors 17
Cassianne Robinson-Cohen
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 14
Jamie P Dwyer
University of Utah Health
Career Start Year 2005
Number of shared co-authors 2
Sankar D Navaneethan
Selzman Institute for Kidney Health, Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 10
Nisha Bansal
Kidney Research Institute, University of Washington
Career Start Year 2003
Number of shared co-authors 13
Martin H de Borst
University Medical Center Groningen
Career Start Year 2003
Number of shared co-authors 8
Bryan Kestenbaum
University of Washington
Career Start Year 2002
Number of shared co-authors 23
Samir M Parikh
The Ohio State University Wexner Medical Center
Career Start Year 2002
Number of shared co-authors 26
Sandeep K Mallipattu
Stony Brook School of Medicine
Career Start Year 2001
Number of shared co-authors 3
Sharidan K Parr
Health Services Research and Development
Career Start Year 2001
Number of shared co-authors 2
Rajesh Mohandas
LSU Health New Orleans School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Michael G Shlipak
University of California san francisco
Career Start Year 1999
Number of shared co-authors 20
Gearoid M McMahon
Brigham and Women's Hospital, MA Harvard Medical School
Career Start Year 1999
Number of shared co-authors 8
Lynda A Szczech
FibroGen Inc.
Career Start Year 1997
Number of shared co-authors 1
Michael Rudnicki
Medical University Innsbruck
Career Start Year 1997
Number of shared co-authors 6
Morgan E Grams
New York University Grossman School of Medicine
Career Start Year 1996
Number of shared co-authors 16
Rohan John
University of Toronto
Career Start Year 1996
Number of shared co-authors 6
Afshin Parsa
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 15
Hans-Joachim Anders
University Hospital of the Ludwig Maximilians University Munich
Career Start Year 1995
Number of shared co-authors 13
Jun Oh
Konyang University Hospital
Career Start Year 1993
Number of shared co-authors 10
Andrew A House
The Lilibeth Caberto Kidney Clinical Research Unit, Western University
Career Start Year 1993
Number of shared co-authors 2
Edward D Siew
Vanderbilt O'Brien Center for Kidney Disease, Vanderbilt University Medical Center
Career Start Year 1993
Number of shared co-authors 14
Isaac E Stillman
Mount Sinai Hospital
Career Start Year 1992
Number of shared co-authors 4
Rakesh Malhotra
University of California San Diego
Career Start Year 1989
Number of shared co-authors 2
Carsten A B??ger
Hospital Traunstein, University Hospital Regensburg
Career Start Year 1988
Number of shared co-authors 11
Brad H Rovin
the Ohio State University Wexner Medical Center
Career Start Year 1980
Number of shared co-authors 25

Collaborators

Matthias Kretzler
University of Michigan ann arbor
Co-authored papers 32
Jeffrey B Hodgin
University of Michigan ann arbor
Co-authored papers 18
Laura Barisoni
Duke University
Co-authored papers 13
Debbie S Gipson
University of Michigan ann arbor
Co-authored papers 12
Viji Nair
University of Michigan-Ann Arbor
Co-authored papers 11
Sean Eddy
University of Michigan ann arbor
Co-authored papers 10
Andrea L Oliverio
University of Michigan ann arbor
Co-authored papers 7
Jonathan P Troost
Michigan Institute for Clinical and Health Research
Co-authored papers 7
Wenjun Ju
University of Michigan ann arbor
Co-authored papers 6
Rajasree Menon
University of Michigan Medical School ann arbor
Co-authored papers 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Felix Eichinger
University of Michigan ann arbor
Co-authored papers 6
Olga G Troyanskaya
Lewis-Sigler Institute for Integrative Genomics, Princeton University
Co-authored papers 6
Bradley Godfrey
University of Michigan ann arbor
Co-authored papers 6
Michelle R Denburg
Children's Hospital of Philadelphia
Co-authored papers 5
Amy K Mottl
Co-authored papers 5
Celine C Berthier
University of Michigan ann arbor
Co-authored papers 5
Carmen Avila-Casado
University Health Network
Co-authored papers 4
Matthew G Sampson
Co-authored papers 4
Susan F Massengill
Levine Children's Hospital at Atrium Health
Co-authored papers 4
Jeffrey B Kopp
National Institutes of Health, National Institute of Diabetes
Co-authored papers 4
Robert G Nelson
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 4
Joseph P Gaut
Co-authored papers 3
Salem Almaani
The Ohio State University College of Medicine
Co-authored papers 3
Ali G Gharavi
Columbia University College of Physicians and Surgeons
Co-authored papers 3
Krzysztof Kiryluk
Columbia University
Co-authored papers 3
Jon B Klein
Co-authored papers 3
Heather N Reich
University Health Network and University of Toronto
Co-authored papers 3
Jennifer A Schaub
University of Michigan ann arbor
Co-authored papers 3
Maddalena Marasa
Columbia University College of Physicians and Surgeons
Co-authored papers 3
Release 1.2